Morgan Joseph Raises Price Target on Spectrum Pharmaceuticals (SPPI) Following FDA Approval of Fusilev for Colorectal Cancer
Go back to Morgan Joseph Raises Price Target on Spectrum Pharmaceuticals (SPPI) Following FDA Approval of Fusilev for Colorectal Cancer| Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) | Delayed: 1.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $7.74 | |||
| Open | $14.68 | 52 Week Low | $3.21 | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $1.03 | EPS | $-0.21 | |||
| Volume | 1,631 | |||||
